Suppr超能文献

中国胱氨酸尿症患者中SLC3A1和SLC7A9基因的异质性突变

Heterogeneous mutations in the SLC3A1 and SLC7A9 genes in Chinese patients with cystinuria.

作者信息

Yuen Y-P, Lam C-W, Lai C-K, Tong S-F, Li P-S, Tam S, Kwan E Y-W, Chan S-Y, Tsang W-K, Chan K-Y, Mak W-L, Cheng C-W, Chan Y-W

机构信息

Department of Pathology, Princess Margaret Hospital, Hong Kong, China.

出版信息

Kidney Int. 2006 Jan;69(1):123-8. doi: 10.1038/sj.ki.5000003.

Abstract

Cystinuria is a recessively inherited aminoaciduria that leads to recurrent urolithiasis. It is caused by the defective transport of cystine and dibasic amino acids in the proximal renal tubules and intestinal epithelium. Two genes responsible for this, SLC3A1 and SLC7A9, are known. Patients with two SLC3A1 mutations are classified as type A cystinuria, whereas patients with two SLC7A9 mutations are classified as type B cystinuria. Few clinical and molecular data have been reported for Asian cystinuria patients. In this study, we determined the molecular basis of cystinuria in eight unrelated Chinese subjects. Coding exons and flanking introns of the SLC3A1 and SLC7A9 genes were directly sequenced after amplification by polymerase chain reaction. Five different SLC3A1 mutations were found. Two missense mutations, D210G and S547L, were novel. The other three SLC3A1 mutations (IVS6+2T>C, R181Q and R365W) have been described previously. In addition, four novel SLC7A9 mutations, C137R, c.730delG, IVS10+2_3delTG and IVS12+3insT, together with two previously reported mutations (A70V and G195R) were found. All patients except one carried compound heterozygous mutations. IVS12+3insT was detected in patients from two families. This is the first molecular genetic study on Chinese cystinuria patients. Three patients with type A cystinuria, two with type B cystinuria, and three carriers of type B cystinuria were identified. Our results suggest that the molecular basis of cystinuria is heterogeneous in our local population.

摘要

胱氨酸尿症是一种隐性遗传的氨基酸尿症,可导致复发性尿石症。它是由近端肾小管和肠上皮细胞中胱氨酸和二碱基氨基酸的转运缺陷引起的。已知有两个基因(SLC3A1和SLC7A9)对此负责。具有两个SLC3A1突变的患者被归类为A型胱氨酸尿症,而具有两个SLC7A9突变的患者被归类为B型胱氨酸尿症。关于亚洲胱氨酸尿症患者的临床和分子数据报道较少。在本研究中,我们确定了8名无亲缘关系的中国受试者胱氨酸尿症的分子基础。通过聚合酶链反应扩增后,对SLC3A1和SLC7A9基因的编码外显子和侧翼内含子进行直接测序。发现了5种不同的SLC3A1突变。两个错义突变D210G和S547L是新发现的。另外三个SLC3A1突变(IVS6+2T>C、R181Q和R365W)先前已有描述。此外,还发现了4种新的SLC7A9突变,C137R、c.730delG、IVS10+2_3delTG和IVS12+3insT,以及两个先前报道的突变(A70V和G195R)。除一名患者外,所有患者均携带复合杂合突变。在两个家族的患者中检测到IVS12+3insT。这是对中国胱氨酸尿症患者的首次分子遗传学研究。鉴定出3例A型胱氨酸尿症患者、2例B型胱氨酸尿症患者和3例B型胱氨酸尿症携带者。我们的结果表明,在我们当地人群中,胱氨酸尿症的分子基础是异质性的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验